# FDA Inspection 1082797 - ReproTech, LLC. - March 06, 2019

Source: https://www.keypedia.com/records/fda_inspections/reprotech-llc/64a4e390-3acf-42cf-9a52-72646c253687
Source feed: FDA_Inspections

> FDA Inspection 1082797 for ReproTech, LLC. on March 06, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082797
- Company Name: ReproTech, LLC.
- Inspection Date: 2019-03-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1228932 - 2024-02-08](https://www.keypedia.com/records/fda_inspections/reprotech-llc/e24b79a9-899a-4f5c-8617-94a1493bfbcb)
- [FDA Inspection 987795 - 2016-05-04](https://www.keypedia.com/records/fda_inspections/reprotech-llc/a9e79306-4118-4467-a3cb-30443659a394)
- [FDA Inspection 889756 - 2014-08-04](https://www.keypedia.com/records/fda_inspections/reprotech-llc/d12297eb-4423-4240-bff1-50a07f8ad2f3)

Company: https://www.keypedia.com/companies/reprotech-llc/ba750420-12a4-4711-a78c-1093c00b5a1d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d